Vitamin D Deficiency and Chronic Diseases

*Vitamin D Deficiency*

jcjo.2017.09.026

gene.2015.04.045

s40618-014-0210-6

dc14-0180

[80] Zhang J, Upala S,

Sanguankeo A. Relationship between vitamin D deficiency and diabetic retinopathy: A meta-analysis. Canadian Journal of Ophthalmology. 2017;**52**(1):39-44. DOI: 10.1016/j.

[81] Zhong X, Du Y, Lei Y, Liu N, Guo Y, Pan T. Effects of vitamin D receptor gene polymorphism and clinical characteristics on risk of diabetic retinopathy in Han Chinese type 2 diabetes patients. Gene. 2015;**566**(2):212-216. DOI: 10.1016/j.

[82] Lv WS, Zhao WJ, Gong SL,

[83] Herrmann M, Sullivan DR,

D: A predictor of macrovascular and microvascular complications in patients with type 2 diabetes. Diabetes Care. 2015;**38**:521-528. DOI: 10.2337/

[84] Scragg R. Vitamin D and type 2 diabetes: Are we ready for a prevention trial? Diabetes. 2008;**57**(10):2565-2566.

Cohen RM, Gastaldelli A, et al. Vitamin D supplementation in patients with type 2 diabetes: The vitamin D for established type 2 diabetes (DDM2) study. Journal of the Endocrine Society. 2018;**2**(4):310-321. DOI: 10.1210/

DOI: 10.2337/db08-0879

[85] Angellotti E, D'Alessio D, Dawson-Hughes B, Nelson J,

Veillard AS, McCorquodale T, Straub IR, Scott R, et al. Serum 25-hydroxyvitamin

Fang DD, Wang B, Fu ZJ, Yan SL, et al. Serum 25-hydroxyvitamin D levels and peripheral neuropathy in patients with type 2 diabetes: A systematic review and meta-analysis. Journal of Endocrinological Investigation. 2015;**38**(5):513-518. DOI: 10.1007/

**210**

js.2018-00015

**213**

**Chapter 11**

**Abstract**

**1. Introduction**

and risk factors.

decades.

Vitamin D and Cardiovascular

Vitamin D deficiency is globally prevalent and has been associated with the pathogenesis and complications of cardiovascular disease (CVD) and its risk factors. Defining these relationships has been challenging, and the clinical applications of vitamin D screening and supplementation for CVD risk prevention and modification have only recently become clearer. Most of the available evidence includes large observational studies and smaller randomized trials that scarcely evaluate CV outcomes as primary endpoints. Additionally, these studies include methodological inconsistencies, making it difficult to ascertain the benefits of vitamin D supplementation. However, more recently, randomized trials have been conducted which utilize CVD outcomes as primary endpoints, while assessing the effects of high dose vitamin D supplementation on CV health. Despite observational evidence as well as a conventional consensus that vitamin D supplementation improves CV health, these studies suggest that vitamin D supplementation likely has no benefit in this

Disease: The Final Chapter?

regard, at least in the follow-up period and populations evaluated.

hypertension, heart failure, renal disease, prevention, vitamin D

**Keywords:** vitamin D deficiency, cardiovascular disease, endothelial function,

Cardiovascular disease (CVD) is the most common cause of death in the developed world and is forecasted to be the leading cause of death and morbidity in developing countries by 2020 [1]. According to the American Heart Association, 9.0% (24.3 million in 2016) of adults (≥20 years of age) in the United States live with CVD (including coronary heart disease, heart failure, and stroke). This number increases to 48.0% when including hypertension [2]. CVD is a multifactorial disease that includes a complex interplay between genetics, environmental factors,

Despite effective measures for control and modification of traditional risk factors, a significant amount of risk remains. Therefore, the identification of easily modifiable novel risk factors has been heavily investigated over the past few

In addition to the well-known relationship between vitamin D and bone health, there has been considerable interest of the possible linkage between vitamin D and CV health due to the expression of the vitamin D receptor (VDR) on cardiomyocytes and vascular cells [3, 4]. Vitamin D plays an extensive role in the regulation of numerous pathways implicated in CVD pathogenesis. Interestingly, various studies note that CVD events are higher in the winter months, a time when vitamin D

*Jeremy I. Purow and Seth I. Sokol*
